Today’s Diabetes Hits Different This American Diabetes Month For Over 133M Americans Living with Prediabetes and Diabetes

The American Diabetes Association® (ADA), the world’s leading diabetes organization, today unveiled this November’s American Diabetes Month® theme to showcase how Today’s Diabetes Hits Different.

Throughout the month, the ADA will elevate the different ways diabetes affects people’s lives through storytelling and highlight the advancements in diabetes technology and treatments.

Many people living with prediabetes or diabetes experience an initial shock after their diagnosis—they worry about costs and care. They wonder how day-to-day life will change and how to manage their new condition—learning about risk factors and complications, building their support community. To bring education, assistance, and advocacy to these communities and their loved ones, ADA’s American Diabetes Month campaign focuses on these actions:

“In 2022 there are different ways to hit back. We have new technologies and research leading to better diabetes management, education resources, and a community that’s stronger than ever,” said Charles D. Henderson, CEO of the ADA. “We won’t stop fighting until we see a world free of diabetes and its burdens.”

The ADA is thankful to our proud supporters, CVS Health® and WW for collaborating with us as we highlight how Today’s Diabetes Hits Different during national diabetes awareness month.

Visit diabetes.org/HitsDifferent to learn more and share your story on social using #hitsdifferent.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”